Spyro Mousses PhD

CEO @ Systems Oncology

[Systems Oncology @SystemsOncology]

There is still an unmet need for patients who progress on all current breast cancer treatment options. This new next-generation SERA compound has proven to have outstanding efficacy and tolerability, which is a strong indicator that SERA2 should produce... https://t.co/d3W7qwxBXs

[OligonInc. @OligonInc]

Oligon to Present at Biocom Global Life Science Partnering Conference.
https://t.co/eBn3qUmQR5

[OligonInc. @OligonInc]

Oligon™ is developing a new class of multimodal RNA therapeutics that can simultaneously silence multiple disease targets with a single RNA molecule. Our proprietary SeekR™ platform is used to digitally engineer and produce self-delivering therapeutics.
https://t.co/m2A5romnw6

[Bayer | Pharmaceuticals @BayerPharma]

Focus on pts + their unmet needs: Bayer to partner w/ @SystemsOncology on a potential new treatment option for women with ER+ #breast cancer. #CollaborateToCure #OncologyInspired

[Bayer | Pharmaceuticals @BayerPharma]

So are we! New #partnership with @SystemsOncology for #breastcancer patients #CollaborateToCure #OncologyInspired

[Bayer | Pharmaceuticals @BayerPharma]

Our #collaboration with @SystemsOncology represents another milestone in growing our footprint in #Oncology and underlines our commitment to this therapeutic area. #CollaborateToCure #OncologyInspired

[Bayer | Pharmaceuticals @BayerPharma]

Our #collaboration with @SystemsOncology on a potential new option in #breastcancer fits our ambition to focus on high medical need + potential for meaningful differentiation. #CollaborateToCure #OncologyInspired

[Seeker @Seeker]

This new laser microscope can reveal cells like never before 😱

[Spyro Mousses PhD @smousses]

See this Instagram video by @terryfoxfoundation https://t.co/WMfKQW42jg

[Spyro Mousses PhD @smousses]

@SystemsOncology This research could explain why some patients with type 2 diabetes have a worse COVID-19 prognosis. It also provides a testable therapeutic intervention (ketogenic diet) that may improve the prognosis of some patients- worth testing this idea clinically. #COVIDー19

[Spyro Mousses PhD @smousses]

@SystemsOncology This research could explain why some patients with type 2 diabetes have a worse COVID-19 prognosis. It also provides a testable therapeutic intervention (ketogenic diet) that may improve the prognosis of some patients- worth testing this idea clinically. #COVIDー19

[Systems Oncology @SystemsOncology]

New research shows the correlation between a #KetogenicDiet and ILC2-mediated airway inflammation in mice. How does lipid metabolism play a role? Check out the link below! https://t.co/fCe6Bf4Qrf

[Spyro Mousses PhD @smousses]

See this Instagram video by @terryfoxfoundation https://t.co/WMfKQW42jg

[Immune Regulation News @Immune_News]

New research published in @ImmunityCP showed that restricting dietary glucose by feeding mice a #KetogenicDiet largely ablated ILC2-mediated airway inflammation by impairing fatty acid metabolism. @LIMES_Bonn https://t.co/R6MdM9ynpB

[Spyro Mousses PhD @smousses]

https://t.co/OBZjdVNgIL

[Immune Regulation News @Immune_News]

New research published in @ImmunityCP showed that restricting dietary glucose by feeding mice a #KetogenicDiet largely ablated ILC2-mediated airway inflammation by impairing fatty acid metabolism. @LIMES_Bonn https://t.co/R6MdM9ynpB

[Spyro Mousses PhD @smousses]

Systems Oncology licenses in cancer therapeutic agents from Texas A&M https://t.co/zGdoVe7SCM

[Systems Oncology @SystemsOncology]

Proud to announce we have received an investment from The Pritzker Organization! Check out the link below to read about our current #discovery #research and pre-clinical #development.
https://t.co/HE1WUTUiGg

[Spyro Mousses PhD @smousses]

@NatureBiotech @Psomagen @wyssinstitute @HMS_SysBio @harvardmed @HarvardDBMI @medialab @BIDMChealth @SinemKSaka1

[PhRMA @PhRMA]

At Innovation Day, @Novartis' Vas Narasimhan says
#clinicaltrials, AI and real-world evidence all offer promise in digital R&D #goboldly